In contrast, gene intervention strategies that directly target RASSF4 achieve precise gene delivery and stable expression through viral and non-viral vector systems, providing more direct and effective treatment options for patients with advanced tumors and metabolic diseases. Here, RASSF4 is linked to metabolic disease.